from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1006/-

LFCtreatmentdescriptionclass of inhibitor

-0.967

Amikacinug/mL Amikacintranslation

-1.881

Cap5-10ug/mL Capreomycintranslation

-2.471

Rox10-50 ug/mL Roxithromycintranslation

-0.111

SM2-5 ug/mL Streptomycintranslation

-1.849

Tet5-10 ug/mL Tetracyclinetranslation

0.787

Rif0.2-5ug/mL Rifampicintranscription

0.472

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.869

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.332

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.061

CPZ10-50 ug/mL Chlorpromazinerespiration

0.069

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.655

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.707

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.080

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.245

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.635

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.005

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.071

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.083

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.020

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.926

KCN5-20 ug/mL Potassium cyaniderespiration

-0.309

NaN30.2-2 mM Sodium aziderespiration

-0.979

Nigericin50 uM Nigericinrespiration

0.246

TRC10-150 ug/mL Triclosanrespiration

-0.339

TRZ10-25 ug/mL Thioridazinerespiration

-0.674

Valinomycin0.5-10 uM Valinomycinrespiration

-0.597

ZnSO42 mM ZnSO4respiration

0.320

menadione6-10 ug/mL Menadionerespiration

0.267

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.401

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.615

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.551

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.754

NRP_1Non-replicating persistence stage 1dosRassociated

0.563

Amp0.2mg/mL AmpicillincellWall

0.129

Cephalexin20-100 ug/mL CephalexincellWall

-0.489

Cerulenin0.32-5 ug/mL CerulenincellWall

0.184

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.733

EMB10-20 ug/mL EthambutolcellWall

-0.271

Eta12-40 ug/mL EthionamidecellWall

-0.168

INH0.2-0.4 ug/mL IsoniazidcellWall

0.008

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.163

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.474

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.385

BZA0.12 mg/mL BenzamidearomaticAmides

0.362

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.165

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.568

H2O24 mM hydrogen peroxideDNAdamaging

-0.584

Levo10 ug/mL LevofloxacinDNAdamaging

0.083

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.366

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.042

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.420

UVUV-irradiationDNAdamaging

0.400

ARP41-4 ug/mL Antitubercular compound ARP4?

0.370

Antimycin12.5-50 ug/mL Antimycin A?

0.417

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.425

PA_110-50 ug/mL Antitubercular compound PA-1?

0.186

PA_2110-50 ug/mL Antitubercular compound PA-21?

-2.802

PA8240.2-2 ug/mL PA-824?

-0.394

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.412

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.164

Verapamil50 uM Verapamil?

0.551

mercaptoethanol2 mM 2-Mercaptoethanol?

0.467

methoxatin10-20 ug/mL Methoxatin?